Valeo Financial Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Valeo Financial Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.03M	Buy	19,221 +12,722	+196%	+$2.01M	0.06%	136
2026 Q2	$1.03M	Buy	6,499 +3,806	+141%	+$515K	0.02%	303
2026 Q1	$344K	Hold	2,693	–	–	0.01%	500
2025 Q4	$328K	Buy	+2,693	New	+$309K	0.01%	587
2025 Q1	–	Sell	-9,595	Closed	-$62.1K	–	783
2024 Q4	$62.1K	Buy	+9,595	New	+$930K	﹤0.01%	714
2021 Q2	–	Sell	-466	Closed	-$63K	–	1855
2021 Q1	$63K	Hold	466	–	–	﹤0.01%	779
2020 Q4	$66K	Buy	466 +250	+116%	+$32K	﹤0.01%	691
2020 Q3	$24K	Sell	216 -84	-28%	-$9.42K	﹤0.01%	881
2020 Q2	$34K	Buy	300 +223	+290%	+$22K	﹤0.01%	872
2020 Q1	$6K	Buy	+77	New	+$6.82K	﹤0.01%	1271
2019 Q3	–	Sell	-300	Closed	-$26K	–	1688
2019 Q2	$26K	Sell	300 -1,225	-80%	-$104K	﹤0.01%	779
2019 Q1	$138K	Hold	1,525	–	–	0.02%	354
2018 Q4	$109K	Hold	1,525	–	–	0.02%	358
2018 Q3	$120K	Hold	1,525	–	–	0.02%	360
2018 Q2	$144K	Buy	1,525 +950	+165%	+$87.3K	0.02%	340
2018 Q1	$50K	Sell	575 -625	-52%	-$57.1K	0.01%	490
2017 Q4	$102K	Buy	+1,200	New	+$101K	0.02%	338

Other funds holding XBI

LHWM

Lake Hills Wealth Management Austin, Texas $218M AUM 31.66% 1-Year Est. Return

AIC

Ayalon Insurance Company Ramat Gan, Israel $1.2B AUM 25.57% 1-Year Est. Return

MWA

MFA Wealth Advisors Pittsburgh, Pennsylvania $589M AUM 19.71% 1-Year Est. Return

MAM

Marotta Asset Management Charlottesville, Virginia $589M AUM 14.57% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

BCG

Breakwater Capital Group Paramus, New Jersey $844M AUM 15.36% 1-Year Est. Return

BONH

Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return

VAG

VisionPoint Advisory Group Dallas, Texas $636M AUM 21.4% 1-Year Est. Return

WAM

Worth Asset Management Dallas, Texas $343M AUM 29.82% 1-Year Est. Return

FHC

First Heartland Consultants Lake St. Louis, Missouri $1.5B AUM 13.03% 1-Year Est. Return

Valeo Financial Advisors's XBI Position: Q3 2026 in Review

Valeo Financial Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 196% in Q3 2026, buying an estimated $2.01M and bringing the position to 19,221 shares worth $3.03M. The position accounts for 0.06% of the portfolio, ranked #136.

Valeo Financial Advisors first reported a position in XBI in Q4 2017 and has held it in 17 quarters since. 39 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

Valeo Financial Advisors held 19,221 shares of State Street SPDR S&P Biotech ETF worth $3.03M as of Q3 2026.
Valeo Financial Advisors bought 12,722 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $2.01M.
State Street SPDR S&P Biotech ETF made up 0.06% of Valeo Financial Advisors's portfolio in Q3 2026, its #136 holding.
Valeo Financial Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and has held it in 17 quarters since.
39 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Valeo Financial Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.